Alex is the co-founder and CEO of Patentext. He’s spent over a decade drafting patents for startups, unicorns like Uber and Dropbox, and everything in between. When he’s not obsessing over Patentext or running his climate tech-focused IP firm, he’s likely training for a triathlon or chasing a very fast border collie.
If you're building something new, you've probably asked yourself: "Do I even need a patent?" It's a reasonable question, and the honest answer is: it depends on what you're building, how you plan to make money, and what threats you're most worried about.
This isn't a checklist article. It's a framework for actually thinking through the decision.
Start with what you're actually trying to protect
Patents protect inventions—novel, non-obvious processes, machines, articles of manufacture, or compositions of matter. If your core asset is a specific technical innovation (a new drug formulation, a hardware mechanism, a novel data processing method), patents are directly relevant.
If your core asset is something else—brand, distribution, customer relationships, proprietary data, regulatory approval—patents may be peripheral or irrelevant.
Be honest about this. A lot of founders pursue patents because they feel like the right thing to do without being clear on what they're actually protecting. That's an expensive mistake.
The three questions that actually matter
1. Can a competitor copy your core innovation?
If the technical mechanism that makes your product work can be reverse-engineered or independently developed, a patent gives you legal recourse. If your advantage comes from execution speed, brand, or network effects that can't be directly copied, a patent provides less incremental protection.
Hardware companies, medical device companies, and companies with novel chemical processes generally have technical innovations that are copyable. Pure software businesses with conventional architectures generally don't benefit as much from patents (though there are exceptions, particularly for specific algorithmic approaches or AI methods with clear technical improvements).
2. What's the realistic threat?
Think through the specific scenario you're worried about. Is it a direct competitor launching a similar product? A large incumbent entering your space? A foreign manufacturer making a cheaper version of your hardware?
Patents are most useful when the threat is a sophisticated actor who would be deterred by legal risk or who you'd have leverage against in a licensing negotiation. They're less useful against offshore manufacturers in jurisdictions where enforcement is difficult, or against fast-moving startups that might be acquired before litigation is resolved.
3. Does your exit path depend on it?
If your likely exit is acquisition by a strategic buyer in a sector that values IP (medical devices, biotech, semiconductors, defense), patents are almost certainly worth the investment. Acquirers in these sectors run IP diligence and will discount the valuation for weak or absent patent portfolios.
If your likely exit is acqui-hire or a revenue multiple, patents matter less. Your acquirer is buying the team and the ARR, not the IP.
The cost-benefit math
A provisionally filed patent costs $2,500–$6,000 in professional fees plus $65–$320 in USPTO fees. A non-provisional through issuance typically costs $12,000–$25,000 including prosecution. Maintenance fees over the patent's life add another $6,000–$13,000.
That's a real investment, especially at the seed stage. The question is whether it's the best use of those dollars given your specific situation.
A few situations where the math clearly works:
- You're 4–6 months from a seed raise and your core innovation is copyable. The "patent pending" signal matters for investors, and the provisional cost is modest relative to the raise.
- You're in a sector where acquirers care deeply about IP. The return on investment comes at exit, not during operation.
- A specific competitor is already moving in your direction and you need to establish priority before they file.
A few situations where the math is harder to justify:
- You're pre-revenue, pre-product, and the invention is still poorly defined. Filing now means either a thin provisional that doesn't hold up, or spending on a full application that might not cover what you ultimately build.
- Your moat is entirely execution-based and patent enforcement in your likely competitive scenarios is unrealistic.
- You're in a sector with a fast product cycle where the invention you're patenting will be obsolete before the patent issues.
An alternative to the binary yes/no
The decision doesn't have to be "file now" or "don't file." A provisional application is a low-cost way to establish a priority date without committing to the full cost of a non-provisional. It buys you 12 months to make the decision with more information: more product development, more investor feedback, more clarity on commercial potential.
For most early-stage founders, the right move is: file a well-drafted provisional on your core innovation before your next public disclosure, then use the 12 months to figure out whether a full non-provisional makes sense.
How Patentext can help
If you've decided patents are worth pursuing, Patentext is built to help you file high-quality patent applications at a fraction of traditional law firm costs. We start with a structured patent strategy—which inventions to file, what claim scope to pursue, how to sequence filings—before drafting a single word of the application.
If you're still evaluating, we can help you think through the decision. Get your patent strategy for free.
Disclaimer: This article is for informational purposes only and does not constitute legal advice. Patent laws are complex and vary by jurisdiction. For personalized guidance, consult a qualified patent attorney or agent.